624PDA phase III trial of muparfostat (PI-88) as adjuvant...

Annals of Oncology 2017 / 09 Vol. 28; Iss. suppl_5

624PDA phase III trial of muparfostat (PI-88) as adjuvant therapy in patients with hepatitis virus related hepatocellular carcinoma (HV-HCC) after resection

Chen, P-J., Lee, P-H., Han, K-H., Fan, J., Cheung, T.T., Hu, R-H., Paik, S.W., Lee, W-C., Chau, G-Y., Jeng, L-B., Wang, H.J., Choi, J.Y., Chen, C-L., Cho, M., Ho, M-C., Wu, C-C., Lee, K.S., Mao, Y., H
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx369.008
Date:
September, 2017
File:
PDF, 46 KB
english, 2017
Conversion to is in progress
Conversion to is failed